Arcturus Therapeutics Ltd
(ARCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 50,754 | 9,349 | -107,998 | -72,732 | -51,169 |
| Depreciation Amortization | 578 | 1,527 | 976 | 559 | 224 |
| Accounts receivable | -89,719 | 603 | 1,323 | 1,120 | -324 |
| Accounts payable and accrued liabilities | 11,788 | -3,112 | 5,335 | -4,422 | -44 |
| Other Working Capital | -62,094 | -12,557 | -47,948 | -28,519 | -6,237 |
| Other Operating Activity | 52,822 | 36,183 | 20,046 | 18,134 | 8,511 |
| Operating Cash Flow | $-35,871 | $31,993 | $-128,266 | $-85,860 | $-49,039 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -691 | -7,726 | -3,919 | -1,733 | -2,111 |
| Investing Cash Flow | $-691 | $-7,726 | $-3,919 | $-1,733 | $-2,111 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -27,364 | -5,000 | -2,000 | N/A | N/A |
| Common Stock Issued | N/A | 2,141 | 1,373 | 593 | 336 |
| Financing Cash Flow | $-27,364 | $-2,859 | $-627 | $593 | $336 |
| Beginning Cash Position | 393,977 | 372,569 | 372,569 | 372,569 | 372,569 |
| End Cash Position | 330,051 | 393,977 | 239,757 | 285,569 | 321,755 |
| Net Cash Flow | $-63,926 | $21,408 | $-132,812 | $-87,000 | $-50,814 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,871 | 31,993 | -128,266 | -85,860 | -49,039 |
| Capital Expenditure | -691 | -7,726 | -3,919 | -1,733 | -2,111 |
| Free Cash Flow | -36,562 | 24,267 | -132,185 | -87,593 | -51,150 |